Your browser doesn't support javascript.
loading
Updated Characterization of Post-OPV Cessation Risks: Lessons from 2019 Serotype 2 Outbreaks and Implications for the Probability of OPV Restart.
Kalkowska, Dominika A; Pallansch, Mark A; Cochi, Stephen L; Kovacs, Stephanie D; Wassilak, Steven G F; Thompson, Kimberly M.
Afiliación
  • Kalkowska DA; Kid Risk, Inc., Orlando, FL, USA.
  • Pallansch MA; National Center for Immunization and Respiratory, Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Cochi SL; Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Kovacs SD; Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Wassilak SGF; Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Thompson KM; Kid Risk, Inc., Orlando, FL, USA.
Risk Anal ; 41(2): 320-328, 2021 02.
Article en En | MEDLINE | ID: mdl-32632925
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Poliomielitis / Vacuna Antipolio Oral / Poliovirus Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Poliomielitis / Vacuna Antipolio Oral / Poliovirus Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article